多国际队列卒中后痴呆预后模型的开发:STROKOG合作研究
本研究利用STROKOG联盟12项研究、10个国家共2663例卒中患者的数据,开发了预测卒中后5年痴呆风险的临床实用模型。模型仅纳入常规临床变量,在开发数据集中表现出良好区分度(C指数0.81),内部-外部交叉验证中汇总C指数为0.70,近期和欧洲队列表现更佳。该工具可帮助识别高风险患者以进行针对性认知监测。
要点
- 基于常规临床变量构建的模型可预测卒中后5年痴呆风险,开发集C指数0.81。
- 内部-外部交叉验证汇总C指数0.70,近期和欧洲队列区分度更高。
- 模型在亚洲队列中略微高估风险,其他地区样本量不足无法可靠评估。
核心结论
- 利用常规临床变量开发并内部-外部验证了卒中幸存者5年痴呆风险模型,在开发集中表现强劲,对近期和欧洲队列泛化良好,但需多样人群外部验证。
研究设计与样本
- 汇总STROKOG联盟12项研究、10个国家的个体参与者数据,共2663例卒中患者,平均年龄67.0岁(SD 11.1),女性占40%,中位随访2.0年(IQR 1.0-5.0)。
主要发现
- 随访期间655例发生痴呆(8.7/100人年)。
- 最终模型纳入年龄、性别、教育、既往卒中史、糖尿病、卒中严重度、2项交互作用(年龄×性别;年龄×卒中严重度)及研究水平变量包括国家当前卫生支出。
- 开发集区分度强(C指数0.81;95%CI 0.75-0.87),校准优秀。
- 内部-外部交叉验证汇总C指数0.70(0.67-0.73),近期队列(2010年后)0.79(0.76-0.82),欧洲队列0.74(0.71-0.78)。
- 亚洲队列风险略被高估,其他地区病例数太少无法可靠评估。
关键数值与推荐
- 痴呆诊断主要依据专家小组共识和算法分类。
- 采用Fine-Gray子分布风险模型估计痴呆概率,将死亡作为竞争事件。
- 候选预测变量通过向后逐步消除法从常规收集的基线临床和卒中相关变量中筛选。
- 模型性能通过C指数和校准评估,采用内部-外部交叉验证评估跨研究、地区和时期的泛化性。
- 基于Excel的风险计算器见补充材料(eAppendix 1)。
临床怎么用
- 该工具可帮助识别卒中后痴呆高风险个体,用于针对性认知监测和随访。
- 通过辅助临床决策和资源规划,提供改善长期结局的实用手段。
局限性
- 亚洲队列中风险略被高估。
- 其他地区病例数太少,无法可靠评估模型表现。
- 需要在多样人群中进一步外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Dementia risk prediction models developed for the general population perform poorly in stroke cohorts. Existing stroke-specific models are few and limited by short prediction horizons or reliance on neuroimaging. The aim of this study was to develop a clinically practical model for predicting 5-year dementia risk after stroke using commonly available variables and individual participant data from the Stroke and Cognition Consortium (STROKOG). METHODS: Data were pooled from 12 studies across 10 countries. Dementia was diagnosed mainly by expert panel consensus and algorithmic classification. Fine-Gray subdistribution hazard models estimated dementia probability, accounting for death as a competing event. Candidate predictors included routinely collected baseline clinical and stroke-related variables, selected through backward stepwise elimination. Model performance was evaluated using discrimination (C-index) and calibration for prediction up to 5 years after stroke. Internal-external cross-validation (IECV) assessed generalizability across studies, regions, and study periods. RESULTS: A total of 2,663 participants (mean age 67.0 years [SD 11.1]; 40% female) were followed for a median of 2.0 years (IQR 1.0-5.0), during which 655 developed dementia (8.7 per 100 person-years). The final model included age, sex, education, history of previous stroke, diabetes, stroke severity, 2 interactions (age × sex; age × stroke severity), and study-level variables including national current health expenditure. An Excel-based risk calculator is available in the Supplement (eAppendix 1). The model demonstrated strong discrimination (C-index: 0.81; 95% CI 0.75-0.87) and excellent calibration in the full data set used for development. In IECV, discrimination was acceptable across individual studies (pooled C-index: 0.70 [0.67-0.73]) and higher in recent (post-2010; 0.79 [0.76-0.82]) and European (0.74 [0.71-0.78]) cohorts. Risks were slightly overestimated in Asian cohorts. Case numbers were too small for reliable assessment in other regions. DISCUSSION: We developed and internally-externally validated a 5-year dementia risk model for stroke survivors using routinely available clinical variables. The model showed strong performance in the full development data set and generalized well to recent and European cohorts, although external validation in diverse populations is needed. This tool can help identify high-risk individuals for targeted cognitive monitoring and follow-up. By informing clinical decision making and resource planning, it offers a practical means to improve long-term outcomes.
引用
- Lo JW, Crawford JD, Desmond DW, et al. Development of a Prognostic Model for Poststroke Dementia Using Multiple International Cohorts: A STROKOG Collaboration Study. Neurology. 2026. PMID: 41525568. doi:10.1212/WNL.0000000000214574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。